Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian J Buchholz

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Gene Medicine|September 27, 2006
Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on holdChristian J Buchholz, Klaus Cichutek
Oncoimmunology|March 14, 2013
Cell type specific gene delivery by lentiviral vectors: New options in immunotherapyQi Zhou, Christian J Buchholz
Molecular Therapy. Methods & Clinical Development|November 13, 2018
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesAnnika M Frank, Christian J Buchholz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 6, 2020
[Chimeric antigen receptors in oncology: clinical applications and new developments]Alexander Michels, Jessica Hartmann, Christian J Buchholz
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
Ligand Coupling to the AAV Capsid for Cell-Specific Gene TransferJohanna Reul, Alexander Muik, Christian J Buchholz
Human Gene Therapy|January 18, 2012
The European hospital exemption clause-new option for gene therapy?Christian J Buchholz, Ralf Sanzenbacher, Silke Schüle
Trends in Biotechnology|October 27, 2015
Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene DeliveryChristian J Buchholz, Thorsten Friedel, Hildegard Büning
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2022
Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platformsAlexander Michels, Naphang Ho, Christian J Buchholz
The Journal of General Virology|February 1, 2003
The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virusOtto Erlwein, Christian J Buchholz, Barbara S Schnierle
Human Gene Therapy|January 21, 2011
Lentiviral vectors targeted to MHC II are effective in immunizationAlexander Ageichik, Christian J Buchholz, Mary K Collins
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Gene Medicine|September 27, 2006
Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on holdChristian J Buchholz, Klaus Cichutek
Oncoimmunology|March 14, 2013
Cell type specific gene delivery by lentiviral vectors: New options in immunotherapyQi Zhou, Christian J Buchholz
Molecular Therapy. Methods & Clinical Development|November 13, 2018
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesAnnika M Frank, Christian J Buchholz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 6, 2020
[Chimeric antigen receptors in oncology: clinical applications and new developments]Alexander Michels, Jessica Hartmann, Christian J Buchholz
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
Ligand Coupling to the AAV Capsid for Cell-Specific Gene TransferJohanna Reul, Alexander Muik, Christian J Buchholz
Human Gene Therapy|January 18, 2012
The European hospital exemption clause-new option for gene therapy?Christian J Buchholz, Ralf Sanzenbacher, Silke Schüle
Trends in Biotechnology|October 27, 2015
Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene DeliveryChristian J Buchholz, Thorsten Friedel, Hildegard Büning
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2022
Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platformsAlexander Michels, Naphang Ho, Christian J Buchholz
The Journal of General Virology|February 1, 2003
The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virusOtto Erlwein, Christian J Buchholz, Barbara S Schnierle
Human Gene Therapy|January 21, 2011
Lentiviral vectors targeted to MHC II are effective in immunizationAlexander Ageichik, Christian J Buchholz, Mary K Collins
Pageof 11